FFCP PHASE1:Hg19::chr11:5264817..5264828,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=3044 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC=4828 | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=0bp_to_NR_001589,uc001mag.2_5end | |||
|cluster_id=chr11:5264817..5264828,- | |||
|coexpression_cluster_id=C644 | |||
|description=CAGE_peak_4_at_HBBP1_5end | |||
|id=chr11:5264817..5264828,- | |||
|ontology_enrichment_celltype=CL:0000764!4.13e-28!2;CL:0000765!4.13e-28!2;CL:0000050!4.13e-28!2;CL:0000038!4.13e-28!2;CL:0000558!4.13e-28!2;CL:0000547!4.13e-28!2;CL:0000549!4.13e-28!2;CL:0000550!4.13e-28!2;CL:0000552!4.13e-28!2;CL:0000763!1.22e-15!112;CL:0000049!1.22e-15!112;CL:0002032!3.42e-10!165;CL:0000837!3.42e-10!165;CL:0000037!1.01e-09!172;CL:0000566!1.01e-09!172;CL:0000988!4.16e-09!182 | |||
|ontology_enrichment_celltype_v019=CL:0000764;3.19e-45;2!CL:0000558;3.19e-45;2 | |||
|ontology_enrichment_celltype_v019_2=CL:0000764,3.19e-45,2;CL:0000765,3.19e-45,2;CL:0000050,3.19e-45,2;CL:0000038,3.19e-45,2;CL:0000558,3.19e-45,2;CL:0000547,3.19e-45,2;CL:0000549,3.19e-45,2;CL:0000550,3.19e-45,2;CL:0000552,3.19e-45,2;CL:0000763,3.81e-16,108;CL:0000049,3.81e-16,108;CL:0002032,8.68e-11,161;CL:0000837,8.68e-11,161;CL:0000037,2.50e-10,168;CL:0000988,8.62e-10,177 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:1036!5.35e-59!8;DOID:8692!1.26e-41!31;DOID:1240!6.72e-33!39;DOID:2531!6.26e-25!51;DOID:0060083!6.26e-25!51;DOID:8552!4.73e-15!1;DOID:0050686!1.66e-08!137 | |||
|ontology_enrichment_disease_v019=DOID:1036;6.92e-44;8!DOID:8692;8.74e-33;31!DOID:8552;1.07e-23;1!DOID:1240;2.56e-22;39!DOID:2531;9.51e-15;51!DOID:0060083;9.51e-15;51 | |||
|ontology_enrichment_disease_v019_2=DOID:1036,6.93e-44,8;DOID:8692,1.96e-34,31;DOID:1240,2.17e-27,39;DOID:8552,1.07e-23,1;DOID:2531,5.93e-21,51;DOID:0060083,5.93e-21,51;DOID:0050686,1.17e-07,137 | |||
|ontology_enrichment_uberon=UBERON:0003127!9.19e-08!2 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.9793098849666,23.0063196901912,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228234679033192,0,0,0,0,0,0,0,0,0,0,0,0,1.23087398947712,3.2454681417118,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,24.5993289212231,2.70714792740617,1.56850027454192,1.00692952185506,0.189753732724185,9.21832158086196,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164185041498678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0852134047591577,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0771741581079447,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0717222053926763,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p4@HBBP1 | |||
}} |
Latest revision as of 07:45, 18 September 2015
Short description: | p4@HBBP1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_4_at_HBBP1_5end |
Coexpression cluster: | C644_chronic_Reticulocytes_acute_CD34_leukemia_liver_schwannoma |
Association with transcript: | 0bp_to_NR_001589, uc001mag.2_5end |
EntrezGene: | HBBP1 |
HGNC: | 4828 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
erythroid lineage cell | 3.19e-45 | 2 |
erythroblast | 3.19e-45 | 2 |
megakaryocyte-erythroid progenitor cell | 3.19e-45 | 2 |
erythroid progenitor cell | 3.19e-45 | 2 |
reticulocyte | 3.19e-45 | 2 |
proerythroblast | 3.19e-45 | 2 |
basophilic erythroblast | 3.19e-45 | 2 |
polychromatophilic erythroblast | 3.19e-45 | 2 |
orthochromatic erythroblast | 3.19e-45 | 2 |
myeloid cell | 3.81e-16 | 108 |
common myeloid progenitor | 3.81e-16 | 108 |
hematopoietic oligopotent progenitor cell | 8.68e-11 | 161 |
hematopoietic multipotent progenitor cell | 8.68e-11 | 161 |
hematopoietic stem cell | 2.50e-10 | 168 |
hematopoietic cell | 8.62e-10 | 177 |
Ontology term | p-value | n |
---|---|---|
chronic leukemia | 6.93e-44 | 8 |
myeloid leukemia | 1.96e-34 | 31 |
leukemia | 2.17e-27 | 39 |
chronic myeloid leukemia | 1.07e-23 | 1 |
hematologic cancer | 5.93e-21 | 51 |
immune system cancer | 5.93e-21 | 51 |
organ system cancer | 1.17e-07 | 137 |